Free Trial

Docusign (NASDAQ:DOCU) Insider Sells $78,040.37 in Stock

Docusign logo with Computer and Technology background

Key Points

  • Robert Chatwani, an insider at Docusign, sold 983 shares of the company's stock for $78,040.37, reducing their ownership by 1.36% to 71,143 shares.
  • Docusign's recent earnings report revealed an EPS of $0.92, exceeding expectations, and a revenue of $800.64 million, up 8.8% year-over-year.
  • The company has initiated a $1 billion share buyback program, indicating that it may believe its stock is undervalued.
  • MarketBeat previews top five stocks to own in October.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) insider Robert Chatwani sold 983 shares of the firm's stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $79.39, for a total transaction of $78,040.37. Following the completion of the transaction, the insider owned 71,143 shares of the company's stock, valued at $5,648,042.77. This trade represents a 1.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Robert Chatwani also recently made the following trade(s):

  • On Wednesday, June 18th, Robert Chatwani sold 22,875 shares of Docusign stock. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25.

Docusign Stock Up 1.8%

Shares of NASDAQ DOCU traded up $1.42 during midday trading on Thursday, reaching $80.24. The company had a trading volume of 3,768,118 shares, compared to its average volume of 2,682,418. Docusign Inc. has a one year low of $55.14 and a one year high of $107.86. The firm's fifty day moving average price is $75.69 and its 200-day moving average price is $79.29. The stock has a market cap of $16.14 billion, a PE ratio of 60.33, a price-to-earnings-growth ratio of 4.18 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to analysts' expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company's quarterly revenue was up 8.8% compared to the same quarter last year. During the same period last year, the company posted $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities research analysts expect that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its board has initiated a share buyback program on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 6.6% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board of directors believes its stock is undervalued.

Institutional Investors Weigh In On Docusign

Hedge funds have recently modified their holdings of the business. Cetera Investment Advisers grew its holdings in Docusign by 11.8% in the 4th quarter. Cetera Investment Advisers now owns 50,329 shares of the company's stock valued at $4,527,000 after buying an additional 5,302 shares in the last quarter. Deutsche Bank AG increased its holdings in Docusign by 26.3% during the 4th quarter. Deutsche Bank AG now owns 546,078 shares of the company's stock worth $49,114,000 after purchasing an additional 113,608 shares during the period. Ethic Inc. purchased a new stake in shares of Docusign during the 4th quarter worth $341,000. Focus Partners Wealth increased its stake in Docusign by 19.8% in the fourth quarter. Focus Partners Wealth now owns 11,063 shares of the company's stock valued at $995,000 after purchasing an additional 1,829 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in shares of Docusign by 13.1% in the 4th quarter. Janus Henderson Group PLC now owns 13,691 shares of the company's stock valued at $1,231,000 after purchasing an additional 1,581 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on DOCU. JMP Securities restated a "market outperform" rating and set a $124.00 target price on shares of Docusign in a research note on Friday, September 5th. Piper Sandler upped their price objective on Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Morgan Stanley lifted their target price on Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research report on Monday. Wells Fargo & Company increased their price objective on shares of Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a research note on Friday, September 5th. Finally, Royal Bank Of Canada boosted their target price on shares of Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $94.14.

Read Our Latest Stock Report on DOCU

About Docusign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.